6-hydroxy-2,6-dimethyl-oct-7-enoic acid | 7047-59-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羟基酸及其衍生物
• 英文名称: 6-hydroxy-2,6-dimethyl-oct-7-enoic acid
• 英文别名: 2,6-Dimethyl-6-hydroxy-octen-7-saeure；6-Hydroxy-2,6-dimethyloct-7-enoic acid
• CAS: 7047-59-8
• 化学式: C₁₀H₁₈O₃
• 分子量: 186.251
• InChiKey: KRHSUSNBQYIYPF-UHFFFAOYSA-N

物化性质

• 沸点：
  112-113 °C(Press: 0.07 Torr)
• 密度：
  1.027±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-hydroxy-2,6-dimethyl-oct-7-enoic acid 在 Lindlar's catalyst 、 PdCl₂/C 喹啉 、 氢气 作用下， 生成 2,6,10,14-Tetramethyl-14-hydroxy-hexadecin-15-saeure
  参考文献：
  名称：

  Weichet,J.; Blaha,L., Collection of Czechoslovak Chemical Communications, 1966, vol. 31, p. 2424 - 2433

  摘要：

  DOI：
• 作为产物：
  描述：

  2-甲基-6-氧代庚酸 在 Lindlar's catalyst 喹啉 、 氢气 作用下， 生成 6-hydroxy-2,6-dimethyl-oct-7-enoic acid
  参考文献：
  名称：

  Weichet,J.; Blaha,L., Collection of Czechoslovak Chemical Communications, 1966, vol. 31, p. 2424 - 2433

  摘要：

  DOI：

文献信息

• METHODS FOR THE DIAGNOSIS OF COLORECTAL CANCER AND OVARIAN CANCER HEALTH STATES
  申请人：Phenomenome Discoveries Inc.

  公开号：EP3165925A1

  公开（公告）日：2017-05-10

  The present invention relates to the diagnosis of colorectal and ovarian cancers (CRC and OC, respectively). The present invention describes the relationship between endogenous small molecules and CRC or OC. Specifically, the present invention relates to the diagnosis of CRC and OC through the measurement of vitamin E isoforms and related metabolites. The present invention also relates to diagnostic markers identified in said method. The present invention relates to the underlying case and pre-symptomatic phases of CRC, the diagnosis of various stages and severity of CRC, the early detection of CRC, monitoring and diagnosing the effect of therapy on CRC and OC health states.

  本发明涉及结直肠癌和卵巢癌（分别为 CRC 和 OC）的诊断。本发明描述了内源性小分子与 CRC 或 OC 之间的关系。具体来说，本发明涉及通过测量维生素 E 同工酶和相关代谢物来诊断 CRC 和 OC。本发明还涉及在所述方法中确定的诊断标记物。本发明涉及 CRC 的基本病例和症状前阶段、CRC 不同阶段和严重程度的诊断、CRC 的早期检测、监测和诊断治疗对 CRC 和 OC 健康状态的影响。
• Methods for diagnosing a colorectal cancer (CRC) health state or change in CRC health state, or for diagnosing risk of developing CRC or the presence of CRC in a subject
  申请人：MED-LIFE DISCOVERIES LP

  公开号：US10697969B2

  公开（公告）日：2020-06-30

  The present invention relates to the diagnosis of colorectal and ovarian cancers (CRC and OC, respectively). The present invention describes the relationship between endogenous small molecules and CRC or OC. Specifically, the present invention relates to the diagnosis of CRC and OC through the measurement of vitamin E isoforms and related metabolites. The present invention also relates to diagnostic markers identified in said method. The present invention relates to the underlying case and pre-symptomatic phases of CRC, the diagnosis of various stages and severity of CRC, the early detection of CRC, monitoring and diagnosing the effect of therapy on CRC and OC health states.

  本发明涉及结直肠癌和卵巢癌（分别为 CRC 和 OC）的诊断。本发明描述了内源性小分子与 CRC 或 OC 之间的关系。具体来说，本发明涉及通过测量维生素 E 同工酶和相关代谢物来诊断 CRC 和 OC。本发明还涉及在所述方法中确定的诊断标记物。本发明涉及 CRC 的基本病例和症状前阶段、CRC 不同阶段和严重程度的诊断、CRC 的早期检测、监测和诊断治疗对 CRC 和 OC 健康状态的影响。
• Weichert,J. et al., Collection of Czechoslovak Chemical Communications, 1966, vol. 31, p. 3607 - 3613
  作者：Weichert,J. et al.

  DOI：——

  日期：——
• METHODS FOR THE DIAGNOSIS OF COLORECTAL CANCER
  申请人：Med-Life Discoveries LP

  公开号：EP3165925B1

  公开（公告）日：2021-09-08
• Methods for the Diagnosis of Colorectal Cancer and Ovarian Cancer by the Measurement of Vitamin E-Related Metabolites
  申请人：Ritchie Shawn

  公开号：US20080255764A1

  公开（公告）日：2008-10-16

  The present invention relates to the diagnosis of colorectal and ovarian cancers (CRC and OC, respectively). The present invention describes the relationship between endogenous small molecules and CRC or OC. Specifically, the present invention relates to the diagnosis of CRC and OC through the measurement of vitamin E isoforms and related metabolites. The present invention also relates to diagnostic markers identified in said method. The present invention relates to the underlying case and pre-symptomatic phases of CRC, the diagnosis of various stages and severity of CRC, the early detection of CRC, monitoring and diagnosing the effect of therapy on CRC and OC health states.